(22R,23R)-3β,22,23-triacetoxystigmast-5-ene | 191151-43-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (22R,23R)-3β,22,23-triacetoxystigmast-5-ene
• 英文别名: (22R,23R)-3β,22,23-triacetoxysitost-5-ene；(22r,23r)-3b,22,23-Triacetoxystigmast-5-ene；[(3S,8S,9S,10R,13S,14S,17R)-17-[(2S,3R,4R,5S)-3,4-diacetyloxy-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
• CAS: 191151-43-6
• 化学式: C₃₅H₅₆O₆
• 分子量: 572.826
• InChiKey: BXFXZBSOXAFHJS-ARCCUZKASA-N

物化性质

• 沸点：
  604.0±35.0 °C(Predicted)
• 密度：
  1.07±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  8.6
• 重原子数：
  41
• 可旋转键数：
  12
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  78.9
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (22R,23R)-3β,22,23-triacetoxystigmast-5-ene 在 吡啶 、 chromium(VI) oxide 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 21.0h， 生成 (2S,3R,4R,5S)-2-((3S,8S,9S,10R,13S,14S,17R)-3-acetoxy-10,13-dimethyl-7-(2-tosylhydrazineylidene)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-5-ethyl-6-methylheptane-3,4-diyl diacetate
  参考文献：
  名称：

  Synthesis of new Δ5-7-oxygenated and Δ5,7-unsaturated brassinosteroid analogs

  摘要：

  We report on the synthesis of the brassinosteroid analogs (22R,23R)-3 beta,7 beta,22,23-tetrahydroxy-stigmast-5-ene (13), (22R,23R)-3 beta,7 alpha,22,23-tetrahydroxy-stigmast-5-ene (15), and (22R,23R)-3 beta-22,23-trihydroxy-stigmast- 5,7-diene (18) by means of the osmium-catalyzed asymmetric dihydroxylation of intermediate 1, available from stigmasterol. This reaction sequence produced the expected (22S,23S)- and (22R,23R)-triols 6 and 7 as well as the 22,23-diketo derivatives 2 and 3. The phytohormone activity of the new brassinosteroid analogs is discussed. (C) 1997 by Elsevier Science Inc.

  DOI：

  10.1016/s0039-128x(97)00008-1
• 作为产物：
  描述：

  豆甾醇 在 吡啶 、 碘 、 溶剂黄146 、 对甲苯磺酰氯 作用下， 以 水 为溶剂， 反应 18.17h， 生成 (22R,23R)-3β,22,23-triacetoxystigmast-5-ene
  参考文献：
  名称：

  Δ5-7-Ketosterols with modified side chain: The synthesis and the effects on viability and cholesterol biosynthesis in Hep G2 cells

  摘要：

  合成的化合物包括：(22E)-30-羟基新植物甾-5,22-二烯-7-酮，(22R,23R)-3β,22,23-三羟基新植物甾-5-烯-7-酮，以及(22R,23R)-30-羟基-22,23-异丙基叉二氧基新植物甾-5-烯-7-酮。研究了所得的7-酮类固醇、7-酮胆固醇，以及(22S,23S)-3β-羟基-22,23-氧化新植物甾-5-烯-7-酮在肝癌细胞株Hep G2中的细胞毒性和对胆固醇生物合成的影响。

  DOI：

  10.1134/s1068162006050141

文献信息

• Cytotoxic derivatives of (22R,23R)-dihydroxystigmastane
  作者：F. V. Drozdov、A. P. Mekhtiev、G. E. Morozevich、V. P. Timofeev、A. Yu. Misharin

  DOI：10.1134/s1068162007030090

  日期：2007.5

  (22R,23R)-22,23-dihydroxystigmast-4-en-3-one, (22R,23R)-22,23-dihydroxystigmast-4-en-3,6-dione, (22R,23R)-3 beta,5 alpha,6 beta,22,23-pentahydroxystigmastane, (22R,23R)-5 alpha,6 alpha-oxido-3 beta,22,23-trihydroxystigmastane, (22R,23R)-5 beta,6 beta-oxido-3 beta,22.23-trihydroxystigmastane, and (22R,23R)3 beta,6 beta,22,23-tetrahydroxystigmast-4-ene were synthesized. Their cytotoxicities were comparatively studied using the MCF-7 line of carcinoma cells of human mammary gland and cells of human hepatoma of the Hep G2 line.

  (22R,23R)-22,23-二羟基白 World-4-烯-3-酮、(22R,23R)-22,23-二羟基白 World-4-烯-3,6-二酮、(22R,23R)-3β,5α,6β,22,23-五羟基白 World烷、(22R,23R)-5α,6α-氧化-3β,22,23-三羟基白 World烷、(22R,23R)-5β,6β-氧化-3β,22,23-三羟基白 World烷以及(22R,23R)-3β,6β,22,23-四羟基白 World-4-烯被成功合成。这些化合物的细胞毒性通过使用人乳腺癌MCF-7细胞系和人肝癌Hep G2细胞系进行了比较研究。
• Synthesis and cytotoxicity evaluation of 22,23-oxygenated stigmastane derivatives
  作者：Alexander Yu. Misharin、Arif R. Mehtiev、Galina E. Morozevich、Yaroslav V. Tkachev、Vladimir P. Timofeev

  DOI：10.1016/j.bmc.2007.10.056

  日期：2008.2.1

  Starting from (22E)-3 alpha,5 alpha-cyclo-6 beta-methoxystigmast-22-ene eighteen derivatives of (22S,23S)-22,23-oxidostigmastane, (22R,23R)-22,23-oxidostigmastane, and (22R,23R)-22,23-dihydroxystigmastane were synthesized and screened for cytotoxicity in human hepatoma Hep G2 cells and human breast carcinoma MCF-7 cells using MTT assay. Four compounds of this series exhibited high cytotoxicity in both cells; three compounds were selectively toxic in MCF-7 cells, one compound was toxic in Hep G2 cells, rather than in MCF-7 cells; four compounds at low concentrations increased MTT test values over the control. (C) 2007 Elsevier Ltd. All rights reserved.